Were You Seriously Harmed by Ozempic, Wegovy, or a GLP-1 Medication?
Canadians who experienced gastroparesis, bowel obstruction, vision loss, or other serious side effects may be entitled to compensation. Find out in minutes — free, with no obligation.
- Free case review — no fees unless you recover
- Serving all Canadian provinces and territories
- Confidential — your information stays private
13
Provinces & territories served
100%
Free case review
0
Upfront fees
Free Case Review — No Obligation
See If Your Experience May Qualify For Review
Answer a few quick questions. It takes about 2 minutes.
Step 1 of 3
By submitting, you consent to be contacted about your claim and agree to our Privacy Policy & Terms.
Millions
GLP-1 prescriptions in Canada
Health Canada data
Gastroparesis
Most common reported injury
Delayed stomach emptying
13
Provinces & territories served
All of Canada
No Fees
Unless your case settles
Contingency basis
Which Medication Did You Take?
Select the drug you took to see specific information about reported side effects and potential legal claims in Canada.
Ozempic
semaglutide injection
Originally approved for type 2 diabetes, Ozempic has been widely prescribed off-label for weight loss. Canadians who experienced serious side effects after taking Ozempic may be eligible for a case review.
- FDA & Health Canada warnings
- Gastroparesis claims
- Vision loss reports
Wegovy
semaglutide injection
Wegovy is approved for chronic weight management. Reports of serious gastrointestinal complications and other adverse effects have led to legal inquiries across Canada and the United States.
- Bowel obstruction reports
- Severe GI symptoms
- Stomach paralysis claims
Foundayo
tirzepatide injection
Foundayo (tirzepatide) is a dual GLP-1/GIP agonist used for weight management. Reports of gastroparesis, bowel obstruction, and severe nausea have led to emerging legal inquiries in Canada.
- Gastroparesis reports
- Bowel obstruction claims
- Severe nausea cases
Mounjaro
tirzepatide injection
Mounjaro is approved for type 2 diabetes management. Like other GLP-1 and GIP agonists, it has been associated with serious gastrointestinal complications and is subject to emerging legal inquiries.
- Gastroparesis claims
- Stomach paralysis reports
- GI obstruction cases
Other GLP‑1 Medications
GLP-1 receptor agonists
Other GLP-1 medications including Rybelsus, Victoza, and Saxenda have also been associated with serious adverse events. If you took any GLP-1 medication, you may still qualify.
- Rybelsus, Victoza, Saxenda
- All GLP-1 agonists
- Comprehensive coverage
How the Case Review Process Works
Getting a case review is straightforward and costs nothing. Here is what to expect.
Answer a Few Questions
Complete our short qualification form. It takes about two minutes. We ask about the medication you took, the side effects you experienced, and your province of residence.
We Review Your Information
Your information is reviewed against our qualification criteria. If your situation may qualify, your details are forwarded to a licensed legal service provider for a free, confidential case review.
Speak With a Case Reviewer
A qualified legal professional contacts you to learn more about your situation. There is no obligation and no fee to speak with them. If they take your case, you typically pay nothing unless there is a recovery.
Reported Side Effects That May Qualify
These are among the serious side effects that have been associated with GLP-1 medications in published research and legal proceedings. This is not a complete list.
Gastroparesis
A condition where the stomach cannot empty itself normally, causing nausea, vomiting, bloating, and severe abdominal pain. GLP-1 medications slow gastric motility and have been linked to gastroparesis.
Stomach Paralysis
Closely related to gastroparesis, stomach paralysis refers to the stomach's inability to contract and move food into the small intestine. It can cause serious nutritional complications.
Bowel Obstruction
Reports of ileus (temporary bowel paralysis) and bowel obstruction have emerged in patients using GLP-1 medications. These can be life-threatening without prompt treatment.
Vision Loss
Emerging research has associated GLP-1 receptor agonists with non-arteritic anterior ischemic optic neuropathy (NAION), a serious condition that can cause irreversible vision loss.
Severe GI Symptoms
Beyond gastroparesis, some patients report severe nausea, vomiting, diarrhea, and abdominal pain that required hospitalization or led to significant weight loss and malnutrition.
Other Serious Effects
Pancreatitis, kidney injury, and other serious complications have also been reported. If you experienced a serious adverse event after taking a GLP-1 medication, you may qualify.
Why Canadians Trust GLP‑1 Compensation
We built this platform to make it easier for affected Canadians to understand their options — without pressure, cost, or confusion.
No Upfront Fees
The legal professionals in our network work on a contingency basis. You pay nothing to have your case reviewed, and typically pay no fees unless your case results in a recovery.
Canada-Wide Service
We serve residents across all Canadian provinces and territories, including Ontario, British Columbia, Alberta, Quebec, and beyond.
Your Information Is Private
Information you submit is handled with care. It is only shared with licensed legal service providers for the purpose of reviewing your potential claim.
Connected to Real Lawyers
GLP-1 Compensation routes your inquiry to qualified legal professionals. We are not a law firm, but our network partners are licensed and experienced in pharmaceutical injury claims.
Think You May Qualify?
If you or a loved one took a GLP-1 medication and experienced a serious side effect, you may have a legal claim. The review is free and carries no obligation.
- You took Ozempic, Wegovy, or another GLP-1 medication
- You experienced a serious side effect
- You are a resident of Canada
- You have not yet retained a lawyer for this matter
Free case review · No obligation · No upfront fees
Your Questions Answered
Common questions about GLP-1 injury claims in Canada.
No. GLP-1 Compensation is a legal lead generation and intake platform. We are not a law firm and we do not provide legal advice. We connect Canadians who may have been harmed by GLP-1 medications with licensed legal service providers who can evaluate their potential claims.
No. Submitting your information through this site does not create an attorney–client relationship. A lawyer–client relationship is only established once you have formally retained a lawyer and both parties have agreed to the representation.
The most common drugs in current Canadian inquiries are Ozempic (semaglutide) and Wegovy (semaglutide). Other GLP-1 medications including Rybelsus, Victoza, Saxenda, and Mounjaro may also be relevant depending on your specific situation.
Commonly reported qualifying injuries include gastroparesis (stomach paralysis), bowel obstruction, severe gastrointestinal symptoms requiring hospitalization, vision loss (including NAION), and other serious adverse events. Each case is reviewed individually — our form will ask about your specific situation.
No. The case review process through GLP-1 Compensation is free and carries no obligation. Legal professionals in our network typically work on contingency — meaning you pay nothing unless your case results in a recovery.
Yes. Each province has its own limitation period for personal injury claims, typically ranging from one to two years from when you knew or should have known about the potential claim. We strongly encourage you to submit your information promptly so a legal professional can advise you on any deadlines that may apply to your situation.
Legal Notice
GLP-1 Compensation is a legal referral and intake service — not a law firm — and does not provide legal advice. No lawyer–client relationship is formed by submitting information, calling any number on this site, or any other communication with us; such a relationship arises only upon formal written retainer with a licensed lawyer. Information submitted may be shared with licensed legal professionals in our referral network for case review.
Individual results vary. Qualifying for a case review does not guarantee a valid legal claim, legal representation, or any compensation. All claims are subject to applicable provincial limitation periods and other legal requirements.
This page does not constitute medical advice and is not a substitute for professional healthcare guidance. Do not discontinue, modify, or adjust any prescribed GLP-1 medication — including Ozempic, Wegovy, or Mounjaro — without first consulting your prescribing physician or healthcare provider.
Information on this site is for general informational purposes only and should not be relied upon as legal advice or as a substitute for advice from a qualified lawyer licensed in your province or territory. This site is intended solely for Canadian residents.